Insmed Incorporated Coverage Initiated at JMP Securities (INSM)
Investment analysts at JMP Securities initiated coverage on shares of Insmed Incorporated (NASDAQ:INSM) in a note issued to investors on Thursday, TheFlyOnTheWall.com reports. The firm set a “market perform” rating on the stock.
Separately, analysts at Leerink Swann reiterated an “outperform” rating on shares of Insmed Incorporated in a research note to investors on Wednesday, August 28th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $20.75.
Shares of Insmed Incorporated (NASDAQ:INSM) traded down 0.19% on Thursday, hitting $15.50. The stock had a trading volume of 856,980 shares. Insmed Incorporated has a one year low of $5.56 and a one year high of $16.50. The stock’s 50-day moving average is $14.97 and its 200-day moving average is $11.71. The company’s market cap is $604.7 million.
Insmed Incorporated (NASDAQ:INSM) last announced its earnings results on Tuesday, August 6th. The company reported ($0.28) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.32) by $0.04. On average, analysts predict that Insmed Incorporated will post $-1.57 earnings per share for the current fiscal year.
Insmed Incorporated (NASDAQ:INSM) is a biopharmaceutical company specializing in recombinant protein drug development.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.